CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction Fine particulate air pollution and hospital admissions and readmissions for acute myocardial infarction in 26 Chinese cities Genotype-Guided Strategy for Oral P2Y12 Inhibitors Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized Trial Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury

Editorial2019 Apr 22;12(8):731-733.

JOURNAL:JACC Cardiovasc Interv. Article Link

Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?

Berry C, Collison D, Mangion K. Keywords: ST-segment elevation myocardial infarction; fractional flow reserve; multivessel disease; percutaneous coronary intervention; remodeling

LINK

Please click on "Article Link" to get further access to this Editorial.